All Stories

  1. Atorvastatin pre-exposure in hypercholesterolemia remedies 27HC mediated dendritic cell dysfunctions in triple-negative breast cancer

    Article • Molecular Therapy Oncology, September 2026, Elsevier

    Dr. Saptak Banerjee

  2. Association of wheatgrass (Triticum aestivum) preparation in regulation of antigen presentation through the immunomodulation and epigenetic modification in acute leukemia

    Article • 3 Biotech, July 2026, Springer Science + Business Media

    Dr Melvin George, Dr. Saptak Banerjee

  3. Tumor-educated-platelets interact with breast cancer-stem-cells via P-selectin-PSGL1 and ensure stemness and metastasis through WNT-β-catenin-VEGF-VEGFR2 intra-cellular signaling: therapeutic modulation by aspirin

    Article • Breast Cancer Research, December 2025, Springer Science + Business Media

    Dr. Saptak Banerjee

  4. 873 Pre-exposure of atorvastatin remedies hypercholesterolemia mediated intratumoral dendritic cell dysfunctions in triple negative breast cancer

    Article • November 2025, BMJ

    Dr. Saptak Banerjee

  5. Trogocytosis at the crossroad of cancer and immunity: mechanisms, implications and therapeutic perspectives

    Article • Frontiers in Cell and Developmental Biology, October 2025, Frontiers

    Dr. Saptak Banerjee

  6. Notch signalling in T cells: bridging tumour immunity and intratumoral cellular crosstalk

    Article • Frontiers in Immunology, October 2025, Frontiers

    Dr. Saptak Banerjee

  7. Mechanistic understanding of Wiskott–Aldrich syndrome protein (WASp)-mediated epigenetic regulation of T helper cell differentiation in acute leukemia

    Article • 3 Biotech, August 2025, Springer Science + Business Media

    Dr. Saptak Banerjee

  8. Reprogrammed immuno-metabolic environment of cancer: the driving force of ferroptosis resistance

    Article • Molecular Cancer, June 2025, Springer Science + Business Media

    Dr. Saptak Banerjee

  9. B-cell editing: An emerging alternative of precision oncotherapy

    Article • January 2025, Elsevier

    Dr. Saptak Banerjee

  10. Evolving Trends in Breast Cancer Immunotherapy: Recent Updates

    Article • Journal of Current Oncological Trends, January 2025, Wolters Kluwer Health

    Dr. Saptak Banerjee

  11. 930 Intervention on intra-tumoral breast cancer stem cells and CD8+ T cell dysregulation: the impact of 2-deoxy-D-glucose

    Article • November 2024, BMJ

    Dr. Saptak Banerjee

  12. Evaluating interaction between tumor educated platelets and cancer stem cells on breast cancer subtypes.

    Article • Journal of Clinical Oncology, August 2024, American Society of Clinical Oncology (ASCO)

    Dr. Saptak Banerjee

  13. Neem Leaf Glycoprotein Disrupts Exhausted CD8+ T-Cell–Mediated Cancer Stem Cell Aggression

    Article • Molecular Cancer Research, May 2024, American Association for Cancer Research (AACR)

    Dr. Saptak Banerjee

  14. Synthesis, structural characterization, solid-state structures, and DNA binding studies of pseudo octahedral mercury(II)-N-heterocyclic carbene (NHC) complex

    Article • Inorganica Chimica Acta, May 2024, Elsevier

    Dr. Saptak Banerjee

  15. Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NFκB

    Article • Cell Communication and Signaling, April 2024, Springer Science + Business Media

    Dr. Saptak Banerjee

  16. The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study

    Article • Frontiers in Immunology, March 2024, Frontiers

    Dr. Saptak Banerjee

  17. High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP

    Article • Frontiers in Immunology, January 2024, Frontiers

    Dr. Saptak Banerjee

  18. Synthesis, structures, electrochemical characterizations, theoretical and anticancer studies of Pd(II)-, Pt(II)- NHC complexes

    Article • Inorganica Chimica Acta, January 2024, Elsevier

    Dr. Saptak Banerjee

  19. Cancer stem cell–immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet

    Article • Frontiers in Immunology, November 2023, Frontiers

    Dr. Saptak Banerjee

  20. Terminally Exhausted CD8+ T Cells Resistant to PD-1 Blockade Promote Generation and Maintenance of Aggressive Cancer Stem Cells

    Article • Cancer Research, March 2023, American Association for Cancer Research (AACR)

    Dr. Saptak Banerjee

  21. Tumor activated platelets induce vascular mimicry in mesenchymal stem cells and aid metastasis

    Article • Cytokine, October 2022, Elsevier

    Dr. Saptak Banerjee

  22. Lactic acid in alternative polarization and function of macrophages in tumor microenvironment

    Article • Human Immunology, May 2022, Elsevier

    Dr. Saptak Banerjee

  23. NLGP regulates RGS5‐TGFβ axis to promote pericyte‐dependent vascular normalization during restricted tumor growth

    Article • The FASEB Journal, April 2022, Wiley

    Dr. Saptak Banerjee

  24. RGS5–TGFβ–Smad2/3 axis switches pro- to anti-apoptotic signaling in tumor-residing pericytes, assisting tumor growth

    Article • Cell Death and Differentiation, May 2021, Springer Science + Business Media

    Dr. Saptak Banerjee

  25. Neem leaf glycoprotein salvages T cell functions from Myeloid-derived suppressor cells-suppression by altering IL-10/STAT3 axis in melanoma tumor microenvironment

    Article • Melanoma Research, February 2021, Wolters Kluwer Health

    Dr. Saptak Banerjee

  26. NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8+ T Cells

    Article • Frontiers in Oncology, March 2020, Frontiers

    Dr. Saptak Banerjee

  27. Neem Leaf Glycoprotein Restrains VEGF Production by Direct Modulation of HIF1α-Linked Upstream and Downstream Cascades

    Article • Frontiers in Oncology, March 2020, Frontiers

    Dr. Saptak Banerjee

  28. Neem leaf glycoprotein regulates function of tumor associated M2 macrophages in hypoxic tumor core: Critical role of IL-10/STAT3 signaling

    Article • Molecular Immunology, December 2016, Elsevier

    Dr. Saptak Banerjee

  29. Neem leaf glycoprotein optimizes effector and regulatory functions within tumor microenvironment to intervene therapeutically the growth of B16 melanoma in C57BL/6 mice

    Article • Trials in Vaccinology, January 2015, Elsevier

    Dr. Saptak Banerjee

  30. Neem Leaf Glycoprotein Prophylaxis Transduces Immune Dependent Stop Signal for Tumor Angiogenic Switch within Tumor Microenvironment

    Article • PLOS One, November 2014, PLOS

    Dr. Saptak Banerjee

  31. A Monoclonal Antibody Against Neem Leaf Glycoprotein Recognizes Carcinoembryonic Antigen (CEA) and Restricts CEA Expressing Tumor Growth

    Article • Journal of Immunotherapy, October 2014, Wolters Kluwer Health

    Dr. Saptak Banerjee

  32. Supraglottic laryngeal tumor microenvironmental factors facilitate STAT3 dependent pro-tumorigenic switch in tumor associated macrophages to render utmost immune evasion

    Article • Immunology Letters, November 2013, Elsevier

    Dr. Saptak Banerjee

  33. Neem leaf glycoprotein is superior than Cisplatin and Sunitinib malate in restricting melanoma growth by normalization of tumor microenvironment

    Article • International Immunopharmacology, September 2013, Elsevier

    Dr. Saptak Banerjee

  34. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients

    Article • Human Immunology, August 2013, Elsevier

    Dr. Saptak Banerjee

  35. Tumor-Derived Vascular Pericytes Anergize Th Cells

    Article • The Journal of Immunology, July 2013, The American Association of Immunologists

    Dr. Saptak Banerjee

  36. Normalization of Tumor Microenvironment by Neem Leaf Glycoprotein Potentiates Effector T Cell Functions and Therapeutically Intervenes in the Growth of Mouse Sarcoma

    Article • PLOS One, June 2013, PLOS

    Dr. Saptak Banerjee

  37. Neem Leaf Glycoprotein Activates CD8+ T Cells to Promote Therapeutic Anti-Tumor Immunity Inhibiting the Growth of Mouse Sarcoma

    Article • PLOS One, January 2013, PLOS

    Dr. Saptak Banerjee

  38. Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: Histological, biochemical and immunological perspectives

    Article • International Immunopharmacology, January 2013, Elsevier

    Dr. Saptak Banerjee

  39. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+Tregs to restrict murine tumor growth

    Article • Immunotherapy, August 2011, Future Medicine

    Dr. Saptak Banerjee